Request Demo
Last update 26 Oct 2025
Recombinant human EGF conjugated vaccine(Biotech Pharmaceuticals)
Last update 26 Oct 2025
Overview
Basic Info
Drug Type Therapeutic vaccine, Genetically engineered subunit vaccine, Conjugated vaccine |
Synonyms Recombinant Human rEGF-P64K/Montanide Vaccine |
Target |
Action antagonists |
Mechanism EGFR antagonists(Epidermal growth factor receptor erbB1 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with Recombinant human EGF conjugated vaccine(Biotech Pharmaceuticals)CTR20131039
癌症治疗用重组人表皮生长因子（EGF）偶联疫苗治疗晚期非小细胞肺癌I期临床研究
[Translation] Phase I clinical study of recombinant human epidermal growth factor (EGF)-coupled vaccine for cancer treatment in the treatment of advanced non-small cell lung cancer
100 Clinical Results associated with Recombinant human EGF conjugated vaccine(Biotech Pharmaceuticals)
Login to view more data
100 Translational Medicine associated with Recombinant human EGF conjugated vaccine(Biotech Pharmaceuticals)
Login to view more data
100 Patents (Medical) associated with Recombinant human EGF conjugated vaccine(Biotech Pharmaceuticals)
Login to view more data
100 Deals associated with Recombinant human EGF conjugated vaccine(Biotech Pharmaceuticals)
Login to view more data
External Link
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
R&D Status
Approved
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Non-Small Cell Lung Cancer | Cuba | - | |
| Non-Small Cell Lung Cancer | Paraguay | - | |
| Non-Small Cell Lung Cancer | Peru | - |
Developing
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Lung Non-Small Cell Carcinoma | Phase 1 | China | 10 Apr 2012 | |
| Advanced Lung Non-Small Cell Carcinoma | Phase 1 | China | 10 Apr 2012 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free